SCHEMBL3345735

SCHEMBL3345735

CCc1cc2cnn(C)c2cc1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 1/20 0.40
MPO P05164 2/20 0.39
CDC7 O00311 1/20 0.38
CHEK1 O14757 1/20 0.35
AURKA O14965 1/20 0.35
DAPK3 O43293 1/20 0.35
CSNK1A1 P48729 1/20 0.35
GSK3A P49840 1/20 0.35
LIMK1 P53667 1/20 0.35
IKBKE Q14164 1/20 0.35
MAPK14 Q16539 1/20 0.35
TAOK1 Q7L7X3 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
CTNNB1 P35222 1/20 0.35
TCF7 P36402 1/20 0.35
TRPM5 Q9NZQ8 1/20 0.35
ERCC1 P07992 1/20 0.35
ERCC4 Q92889 1/20 0.35
PDE1C Q14123 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31238986 0.81 MPO (0.36) USP7MPOCDC7CTNNB1TCF7
SCHEMBL3343371 0.81 HTR2A (0.39) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL17680242 0.80 NOS3 (0.39) USP7MPOCTNNB1TCF7TRPM5
SCHEMBL21603505 0.78 ATAD2 (0.44) USP7MPOCDC7CTNNB1TCF7
SCHEMBL24195801 0.76 MAOB (0.39) USP7MPOCDC7CTNNB1TCF7
SCHEMBL14117414 0.75 MAOB (0.41) USP7CTNNB1TCF7TRPM5ERCC1
SCHEMBL21949440 0.75 TRPA1 (0.49) USP7CTNNB1TCF7TRPM5ERCC1
SCHEMBL29824722 0.74 ATAD2 (0.44) USP7MPOCDC7CTNNB1TCF7
SCHEMBL23531670 0.74 ATAD2 (0.44) USP7MPOCDC7CTNNB1TCF7
SCHEMBL24196291 0.73 MAOB (0.39) USP7MPOCDC7CTNNB1TCF7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372865-B2 Dihydropyridone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-02-12 US disclosed
US-20100160373-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160373-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX3, P2RX1 USP7 4778/4885MPO 3292/4885CDC7 3719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.